Elevated [18F] fluorodopamine turnover in brain of patients with schizophrenia: an [18F] fluorodopa/positron emission tomography study Y Kumakura, P Cumming, I Vernaleken, HG Buchholz, T Siessmeier, ... Journal of Neuroscience 27 (30), 8080-8087, 2007 | 175 | 2007 |
Positron emission tomography in CNS drug discovery and drug monitoring M Piel, I Vernaleken, F Rösch Journal of medicinal chemistry 57 (22), 9232-9258, 2014 | 161 | 2014 |
Brain and Plasma Pharmacokinetics of Aripiprazole in Patients With Schizophrenia: An [ 18 F]Fallypride PET Study G Gründer, C Fellows, H Janouschek, T Veselinovic, C Boy, A Bröcheler, ... American Journal of Psychiatry 165 (8), 988-995, 2008 | 153 | 2008 |
Therapeutic monitoring of new antipsychotic drugs C Hiemke, A Dragicevic, G Gründer, S Hätter, J Sachse, I Vernaleken, ... Therapeutic drug monitoring 26 (2), 156-160, 2004 | 148 | 2004 |
Subchronic haloperidol downregulates dopamine synthesis capacity in the brain of schizophrenic patients in vivo G Gründer, I Vernaleken, MJ Müller, E Davids, N Heydari, HG Buchholz, ... Neuropsychopharmacology 28 (4), 787-794, 2003 | 126 | 2003 |
The striatal and extrastriatal D2/D3 receptor-binding profile of clozapine in patients with schizophrenia G Gründer, C Landvogt, I Vernaleken, HG Buchholz, J Ondracek, ... Neuropsychopharmacology 31 (5), 1027-1035, 2006 | 117 | 2006 |
Parametric mapping of binding in human brain of D2 receptor ligands of different affinities T Siessmeier, Y Zhou, HG Buchholz, C Landvogt, I Vernaleken, M Piel, ... Journal of Nuclear Medicine 46 (6), 964-972, 2005 | 94 | 2005 |
Modulation of [18F] fluorodopa (FDOPA) kinetics in the brain of healthy volunteers after acute haloperidol challenge I Vernaleken, Y Kumakura, P Cumming, HG Buchholz, T Siessmeier, ... Neuroimage 30 (4), 1332-1339, 2006 | 90 | 2006 |
‘Prefrontal’ cognitive performance of healthy subjects positively correlates with cerebral FDOPA influx: An exploratory [18F]‐fluoro‐L‐DOPA‐PET investigation I Vernaleken, HG Buchholz, Y Kumakura, T Siessmeier, P Stoeter, ... Human brain mapping 28 (10), 931-939, 2007 | 74 | 2007 |
Asymmetry in dopamine D2/3 receptors of caudate nucleus is lost with age I Vernaleken, C Weibrich, T Siessmeier, HG Buchholz, F Rösch, A Heinz, ... Neuroimage 34 (3), 870-878, 2007 | 74 | 2007 |
The impact of dopamine on aggression: an [18F]-FDOPA PET Study in healthy males T Schlüter, O Winz, K Henkel, S Prinz, L Rademacher, J Schmaljohann, ... Journal of neuroscience 33 (43), 16889-16896, 2013 | 71 | 2013 |
Therapeutic plasma concentrations of antidepressants and antipsychotics: lessons from PET imaging G Gründer, C Hiemke, M Paulzen, T Veselinovic, I Vernaleken Pharmacopsychiatry 21 (06), 236-248, 2011 | 71 | 2011 |
PET Studies of Net Blood—Brain Clearance of FDOPA to Human Brain: Age-Dependent Decline of [18F]Fluorodopamine Storage Capacity Y Kumakura, I Vernaleken, G Gründer, P Bartenstein, A Gjedde, ... Journal of Cerebral Blood Flow & Metabolism 25 (7), 807-819, 2005 | 70 | 2005 |
[18F]Fluoroethylflumazenil: a novel tracer for PET imaging of human benzodiazepine receptors G Gründer, T Siessmeier, C Lange-Asschenfeldt, I Vernaleken, ... European journal of nuclear medicine 28, 1463-1470, 2001 | 70 | 2001 |
Coping with unemployment: The impact of unemployment on mental health, personality, and social interaction skills B Pelzer, S Schaffrath, I Vernaleken Work 48 (2), 289-295, 2014 | 68 | 2014 |
High striatal occupancy of D2-like dopamine receptors by amisulpride in the brain of patients with schizophrenia I Vernaleken, T Siessmeier, HG Buchholz, S Härtter, C Hiemke, P Stoeter, ... International Journal of Neuropsychopharmacology 7 (4), 421-430, 2004 | 67 | 2004 |
Bithalamical deep brain stimulation in Tourette syndrome is associated with reduction in dopaminergic transmission I Vernaleken, J Kuhn, D Lenartz, M Raptis, W Huff, H Janouschek, ... Biological psychiatry 66 (10), e15-e17, 2009 | 65 | 2009 |
Quantification of D2-like dopamine receptors in the human brain with 18F-desmethoxyfallypride G Gründer, T Siessmeier, M Piel, I Vernaleken, HG Buchholz, Y Zhou, ... Journal of Nuclear Medicine 44 (1), 109-116, 2003 | 65 | 2003 |
Aripiprazole in the pharmacotherapy of Gilles de la Tourette syndrome in adult patients W Kawohl, F Schneider, I Vernaleken, I Neuner The world journal of biological psychiatry 10 (4-3), 827-831, 2009 | 59 | 2009 |
Age-dependent decline of steady state dopamine storage capacity of human brain: an FDOPA PET study Y Kumakura, I Vernaleken, HG Buchholz, P Borghammer, E Danielsen, ... Neurobiology of aging 31 (3), 447-463, 2010 | 56 | 2010 |